Sign up to receive the latest announcements on Woke Pharmaceuticals....
Latest Announcements
18.10.22
Press Release
Woke and University of Sydney Sign Term Sheet for Phase II trial of WP002 Psilocybin in Alcohol Use Disorder
Read More16.08.22
Press Release
Woke and Swinburne University Sign Memorandum of Understanding to Develop WP002 Psilocybin-assisted Psychotherapy Phase IIB trial in Treatment-Resistant Depression
Read More12.08.22
Press Release
Woke and QIMR Berghofer Sign Letter of Intent for Clinical Trial of WP002 Psilocybin in Prolonged Grief
Read MoreLatest Presentations
Latest Media
11.07.22
Media
Can microdosing psychedelics improve your mental health? Here's what the science says
Read More